Lee Krug

Lee Krug has extensive experience in the oncology field, holding leadership positions in clinical development at AstraZeneca from November 2019 to September 2020, including VP, Head of Clinical Development, Late Development Oncology, VP, Global Clinical Head, Late Development Oncology, and VP, Global Product Lead, Late Development Oncology. Prior to that, Lee served as Disease Area Head for Immuno-Oncology at Bristol-Myers Squibb from July 2015 to April 2018. Lee's clinical expertise was further developed at Memorial Sloan Kettering Cancer Center, where an Associate Attending Physician role in the Thoracic Oncology Service was held from July 2000 to July 2015. Lee completed an Oncology Fellowship at Memorial Sloan Kettering Cancer Center and a residency at Johns Hopkins Hospital.